Addus HomeCare Co. (NASDAQ:ADUS) Shares Acquired by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC increased its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 2.3% in the third quarter, HoldingsChannel reports. The firm owned 10,600 shares of the company’s stock after acquiring an additional 234 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Addus HomeCare were worth $1,410,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. raised its position in Addus HomeCare by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock worth $131,910,000 after buying an additional 19,027 shares during the last quarter. Point72 Asset Management L.P. raised its holdings in shares of Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after purchasing an additional 315,602 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after purchasing an additional 5,421 shares during the period. Principal Financial Group Inc. boosted its holdings in Addus HomeCare by 20.9% in the second quarter. Principal Financial Group Inc. now owns 430,444 shares of the company’s stock valued at $49,979,000 after purchasing an additional 74,488 shares during the last quarter. Finally, Millennium Management LLC boosted its holdings in Addus HomeCare by 412.7% in the second quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock valued at $36,739,000 after purchasing an additional 254,705 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total value of $65,015.00. Following the completion of the sale, the director now owns 3,866 shares in the company, valued at approximately $502,695.98. This represents a 11.45 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 75.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 22,917 shares of company stock worth $3,050,082. Corporate insiders own 4.60% of the company’s stock.

Analysts Set New Price Targets

ADUS has been the subject of a number of recent research reports. KeyCorp started coverage on Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective for the company. Stephens boosted their price target on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday. Oppenheimer boosted their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Finally, TD Cowen raised their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Addus HomeCare currently has a consensus rating of “Moderate Buy” and a consensus target price of $131.63.

Addus HomeCare Stock Down 1.0 %

ADUS opened at $122.07 on Friday. The company has a market cap of $2.21 billion, a PE ratio of 27.93, a price-to-earnings-growth ratio of 2.20 and a beta of 1.04. Addus HomeCare Co. has a twelve month low of $85.43 and a twelve month high of $136.12. The company has a 50-day moving average price of $129.12 and a 200 day moving average price of $122.06.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.03 earnings per share. As a group, sell-side analysts expect that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.